FOLH1 and neoplasm: Although our present study was conducted over a long period of time and the latest imaging modalities were not used in all patients, both mpMRI and prostate-specific membrane antigen PET (PSMA-PET)/CT excel in accurately detecting extraprostatic and intraprostatic tumor burdens, significantly influencing RT strategies [28].